Proctosigmoiditis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-05-14
Clinical Trial Update: Role of FCI in the Detection of Proctosigmoiditis Caused by IBD [NA]
A clinical trial evaluating the role of FCI in detecting proctosigmoiditis in inflammatory bowel disease has been withdrawn.